Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Aveiro – page 3

46 clinical trials in Aveiro, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Aveiro at a glance
46
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

46 trials in Aveiro

Open in trial search

Study on the Effects of Itepekimab for Patients with Chronic Rhinosinusitis Without Nasal Polyps

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Migraine

Not recruiting

Study on Atogepant for Preventing Menstrual Migraine in Women

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Type 2 diabetes mellitus+1

Not recruiting

Study comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Aveiro

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular conditions, including studies of new treatments for acute myocardial infarction and hypertrophic cardiomyopathy. Researchers are evaluating novel therapies for stroke prevention and heart-related complications.

  • Hypertrophic Cardiomyopathy Treatment
  • Stroke Prevention Therapies
  • Acute Myocardial Infarction Management

Advanced studies targeting improved outcomes in patients with various cardiac conditions through innovative therapeutic approaches.

02 Respiratory Medicine

Research initiatives addressing chronic respiratory conditions, with particular emphasis on chronic rhinosinusitis and COPD. Studies are evaluating new therapeutic agents for managing symptoms and improving patient quality of life.

  • Chronic Rhinosinusitis Treatment
  • COPD Management
  • Nasal Polyps Therapy

Comprehensive trials exploring both symptomatic relief and long-term disease modification strategies.

03 Metabolic Disorders

Clinical investigations into metabolic conditions, focusing on obesity, diabetes, and related complications. Studies are examining new treatments for hypertriglyceridemia and innovative approaches to weight management.

  • Obesity Treatment
  • Diabetic Complications
  • Lipid Management

Groundbreaking research aimed at developing effective therapies for metabolic disorders and their associated complications.

04 Hematology Research

Studies investigating treatments for blood disorders, particularly focusing on conditions like Paroxysmal Nocturnal Hemoglobinuria and various forms of neutropenia. Researchers are evaluating novel therapeutic approaches.

  • PNH Treatment Development
  • Neutropenia Management
  • Blood Disorder Therapies

Innovative clinical trials exploring new treatment options for rare and chronic blood conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.